Increasing halitosis disease burden across the globe is expected to boost industry growth.
According to a new report by Reports and Data, the Global Halitosis Therapy Market size was valued at USD 10.75 Billion in 2020 and is forecast to exceed USD 28.53 Billion in terms of revenue, at a CAGR of 13.1% through 2028. The market growth is driven by increased consumption of tobacco products and rising prevalence of periodontal diseases across the globe.
Halitosis is a condition of bad breath arising due to one of the many factors, including bad oral hygiene, side-effect of medications, alcohol consumption, smoking, crash diets, diabetes, GERD, lactose intolerance, and gum diseases, and others. It is a clinical condition that generally leads to social restraints.
The condition has become a major issue across the globe where a moderate case of halitosis is quite high, severe cases are limited to 5% of the population only. In the US, approximately 80 million people spend more than USD 10.75 Billion annually on oral hygiene products. Rising prevalence of halitosis coupled with increasing awareness regarding the disease and its therapy will foster halitosis market size through 2028.
The rapid adoption of AI, ML, and IoT and robust data management processes has made the hospitals and clinical settings smarter. New technologies and solutions have improved the normal medical processes such as clinical diagnosis, therapy, diseases management, and monitoring patient recovery after discharge. Rapid digitalization and increasing adoption of virtual care and telemedicine is further expected to positively impact the revenue growth of the market going ahead.
Emergence of new healthcare and telemedicine startups, increasing number of collaborations among healthcare facilities and research institutions, and rising focus on patient engagement solutions has further fueled revenue growth of the market. Key companies are forming strategic alliances and collaborative ventures such as mergers and acquisitions, joint ventures, partnerships, manufacturing and licensing agreements, and product launches among others.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/1469
Leading Players Analyzed in the Report:
Colgate-Palmolive Company, Dr. Harold Katz, LLC, All USA Partners LLC., Rowpar Pharmaceuticals, Inc., Listerine, Abbott, AstraZeneca, Novartis, Oral B, GSK, Philips Oral Healthcare, Pfizer, and Roche among others.
Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter’s Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered in the report.
The report further discusses in detail the regional spread of the global Halitosis Therapy market along with analysis of production and consumption patterns, import/export analysis, supply and demand ratio, market share and size based on volume and value, trends and demands, revenue share, and presence of the key players of the market.
Order this Report @ https://www.reportsanddata.com/report-pricing/1469
Key Regions Studied in the Report:
· North America (U.S., Canada, Mexico)
· Europe (U.K., Italy, Germany, France, Rest of Europe)
· Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
· Latin America (Chile, Brazil, Argentina, Rest of Latin America)
· Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Segmentation based on Types:
Type Outlook (Revenue, USD Billion; 2020-2028)
- Pathological
- Non-Pathological
Indication Outlook (Revenue, USD Billion; 2020-2028)
- Lungs
- Liver
- Respiratory
- Systemic
- Gastrointestinal
- Others
Diagnostic Tests Outlook (Revenue, USD Billion; 2020-2028)
- Gas Chromatography
- Halimeter
- Beta-galactosidase activity assay
- Others
Drug Therapy Outlook (Revenue, USD Billion; 2020-2028)
- Antiseptic
- Antacids
- Ranitidine
- Other
End Users Outlook (Revenue, USD Billion; 2020-2028)
- Hospitals
- Clinics
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1469
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
Explore More Industry Research by Reports and Data:
In-Vitro Diagnostics (IVD) Quality Control Market @ https://ipv4.google.com/url?q=https://www.biospace.com/article/in-vitro-diagnostics-ivd-quality-control-market-size-2022-2028-multiple-level-quality-control-analysis-and-identification-of-critical-analytical-system-issues-are-expected-to-bolster-growth-of-this-market/
Digital Pathology Market @ https://ipv4.google.com/url?q=https://www.biospace.com/article/digital-pathology-market-size-2022-2030-increasing-adoption-of-digital-pathology-to-enhance-lab-efficiency/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
